AEMD logo

Aethlon Medical, Inc. Stock Price

NasdaqCM:AEMD Community·US$1.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

AEMD Share Price Performance

US$0.69
-13.81 (-95.21%)
US$0.69
-13.81 (-95.21%)
Price US$0.69

AEMD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with excellent balance sheet.

6 Risks
0 Rewards

Aethlon Medical, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$7.2m

Other Expenses

-US$7.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-3.02
0%
0%
3.6%
View Full Analysis

About AEMD

Founded
1984
Employees
9
CEO
James Frakes
WebsiteView website
www.aethlonmedical.com

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Recent AEMD News & Updates

Recent updates

No updates